RadNet Price Target Raised to $57.00/Share From $51.00 by Barclays
Barclays Reaffirms Their Hold Rating on Radnet (RDNT)
RadNet Analyst Ratings
RadNet Analyst Ratings
Analysts Conflicted on These Healthcare Names: Amylyx Pharmaceuticals Inc (AMLX), Centene (CNC) and Radnet (RDNT)
RadNet Analyst Ratings
Barclays Remains a Hold on Radnet (RDNT)
RadNet Analyst Ratings
Radnet (RDNT) Gets a Buy From Truist Financial
Truist Securities Adjusts Price Target on RadNet to $63 From $55, Maintains Buy Rating
RadNet Analyst Ratings
Barclays Keeps Their Hold Rating on Radnet (RDNT)
What 4 Analyst Ratings Have To Say About RadNet
RadNet Analyst Ratings
RadNet Analyst Ratings
RadNet Analyst Ratings
Analysts Are Bullish on Top Healthcare Stocks: Sotera Health (SHC), Radnet (RDNT)
Analysts Offer Insights on Healthcare Companies: Radnet (RDNT), Chemed (CHE) and UnitedHealth (UNH)
RadNet Analyst Ratings
Radnet's Robust Performance and Growth Prospects Justify Macdonald's Buy Rating
No Data